Search
-
Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse
(Drug Safety. pp. 1193-1208, 2021-09-15)Article de revueOpen access -
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
(European Journal of Clinical Pharmacology. vol. 78, pp. 1981-1990, 2022-10-26)Article de revue -
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
(Diabetes Care, 2022-11-10)Article de revue -
A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis
(British Journal of Clinical Pharmacology, 2021-03-13)Article de revue -
High prevalence of spin was found in pharmacovigilance studies usingdisproportionality analyses todetectsafetysignals: a meta-epidemiologicalstudy: Spin in pharmacovigilance disproportionality analyses
(Journal of Clinical Epidemiology. vol. 138, pp. 73-79, 2021-06-26)Article de revue -
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
(Thérapie, 2021-04-02)Article de revue -
Trends in use of benzodiazepines and Z-drugs in France from 2012 to 2020
(Therapies, 2022-12-09)Article de revue -
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Bidisciplinary dermatology-pharmacovigilance consultations: Results of a two-year study
(Annales de Dermatologie et de Vénéréologie, 2022-12-07)Article de revue -
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
(Therapies, 2023-03-07)Article de revue